-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VQ53GgllSSVaEJ79YtcAg77j5jSgP7IM5lAwVT43l3jDETUXBCPEazd9inz3fiWP +uTeile7uKxrpGsA7kxybw== 0000950133-05-004439.txt : 20051003 0000950133-05-004439.hdr.sgml : 20051003 20051003104842 ACCESSION NUMBER: 0000950133-05-004439 CONFORMED SUBMISSION TYPE: POS AM PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20051003 DATE AS OF CHANGE: 20051003 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GUILFORD PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000918066 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521841960 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: POS AM SEC ACT: 1933 Act SEC FILE NUMBER: 333-108133 FILM NUMBER: 051116011 BUSINESS ADDRESS: STREET 1: 6611 TRIBUTARY STREET CITY: BALTIMORE STATE: MD ZIP: 21224 BUSINESS PHONE: 4106316300 MAIL ADDRESS: STREET 1: 6611 TRIBUTARY STREET CITY: BALTIMORE STATE: MD ZIP: 21224 POS AM 1 w13298posam.htm POST-EFFECTIVE AMENDMENT NO.1 S-3 posam
 

As filed with the Securities and Exchange Commission on October 3, 2005

Registration No. 333-108133
 
 

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_______________

POST-EFFECTIVE AMENDMENT NO. 1
TO
FORM S-3
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933

GUILFORD PHARMACEUTICALS INC.

(Exact name of registrant as specified in its charter)
     
Delaware   52-1841960
(State or other jurisdiction of incorporation or organization)   (I.R.S. Employer Identification No.)

6611 Tributary Street
Baltimore, MD 21224
(410) 631-6300

(Address, including zip code, and telephone number,
including area code, of registrant’s principal executive offices)


Dean J. Mitchell
President and Chief Executive Officer
Guilford Pharmaceuticals, Inc.
6611 Tributary Street
Baltimore, MD 21224
(410) 631-6300

(name, address, including zip code, and telephone number, including area code, of agent for service)

Copies to:

Michael J. Silver
Hogan & Hartson L.L.P.
111 S. Calvert Street, Suite 1600
Baltimore, Maryland 21202
(410) 659-2741

DEREGISTRATION OF SECURITIES

     The Registration Statement on Form S-3 (Registration No. 333-108133) (the “Registration Statement”) of Guilford Pharmaceuticals Inc., a Delaware Corporation (the “Registrant”), pertaining to the registration of up to $69,354,000 principal amount of convertible debt securities (the “Notes”) and 11,114,423 shares of common stock (the “Shares”) issuable upon conversion of the Notes, to which this Post-Effective Amendment No. 1 relates, was declared effective by the Securities and Exchange Commission on November 12, 2003. The Registrant’s contractual obligation to maintain the effectiveness of the Registration Statement has terminated and the Registrant is terminating all offerings of Notes and Shares pursuant to the Registration Statement. In accordance with an undertaking made by the Registrant in the Registration Statement to remove from registration, by means of a post-effective amendment, any securities of the Registrant that remain unsold at the termination of the offering, the Registrant hereby removes from registration all Notes and Shares registered under the Registration Statement that remain unsold.

 

 
 

 

 

 

SIGNATURES

     Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this Post-Effective Amendment No. 1 to the Registration Statement on Form S-3 to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Baltimore, State of Maryland, on October 3, 2005.

                                                         GUILFORD PHARMACEUTICALS INC.
         
     
  By:   /s/ Dean J. Mitchell    
    Dean J. Mitchell
President and Chief Executive Officer		  
       
 

     Pursuant to the requirements of the Securities Exchange Act of 1934, this Post-Effective Amendment No. 1 to the Registration Statement has been signed by the following persons in the capacities and on the dates indicated:
         
     
Date:   October 3, 2005  /s/ Dean J. Mitchell    
  Dean J. Mitchell   
  President, Chief Executive Officer and Director (Principal Executive Officer)   
 
         
     
Date:   October 3, 2005  /s/ William F. Spengler    
  William F. Spengler   
  Executive Vice President and Chief Financial Officer (Principal Financial Officer)   
 
         
     
Date:   October 3, 2005  /s/ Andrew J. Jeanneret    
  Andrew J. Jeanneret   
  Vice President, Controller and Chief Accounting Officer (Principal Accounting Officer)   
 
         
     
Date:   October 3, 2005  /s/ George L. Bunting, Jr.*    
  George L. Bunting, Jr.   
  Director   
 
         
     
Date:   October 3, 2005  /s/ Barry M. Fox*    
  Barry M. Fox   
  Director   
 
         
     
Date:   October 3, 2005  /s/ Joseph Klein, III*    
  Joseph Klein, III   
  Director   

 

 

         
         
     
Date:   October 3, 2005  /s/ Elizabeth M. Greetham*    
  Elizabeth M. Greetham   
  Director   
 
         
     
Date:   October 3, 2005  /s/ Ronald M. Nordmann*    
  Ronald M. Nordmann   
  Director   
 
         
     
Date:   October 3, 2005  /s/ Solomon H. Snyder, M.D.*    
  Solomon H. Snyder, M.D.   
  Director   
 

*    pursuant to power of attorney

By: /s/ Michael J. Silver
 
Michael J. Silver
Attorney-in-Fact

 

-----END PRIVACY-ENHANCED MESSAGE-----